NANOSTRING TECHNOLOGIES INC's ticker is NSTG and the CUSIP is 63009R109. A total of 155 filers reported holding NANOSTRING TECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is 1.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,930,436 | -13.1% | 2,285,137 | +104.7% | 0.15% | -2.5% |
| Q2 2023 | $4,521,388 | -62.9% | 1,116,392 | -9.2% | 0.16% | -62.9% |
| Q1 2023 | $12,175,050 | +21.3% | 1,229,803 | -2.3% | 0.42% | +10.7% |
| Q4 2022 | $10,033,967 | +54.8% | 1,258,967 | +148.1% | 0.38% | +41.0% |
| Q3 2022 | $6,480,000 | +10.8% | 507,405 | +10.2% | 0.27% | +22.6% |
| Q2 2022 | $5,849,000 | -52.0% | 460,542 | +31.3% | 0.22% | -40.9% |
| Q1 2022 | $12,187,000 | -17.7% | 350,719 | 0.0% | 0.37% | -9.2% |
| Q4 2021 | $14,811,000 | +9.9% | 350,719 | +25.0% | 0.41% | +8.7% |
| Q3 2021 | $13,475,000 | -25.9% | 280,671 | 0.0% | 0.38% | -10.0% |
| Q2 2021 | $18,185,000 | -1.4% | 280,671 | 0.0% | 0.42% | +2.4% |
| Q1 2021 | $18,443,000 | +2.1% | 280,671 | +3.9% | 0.41% | -1.0% |
| Q4 2020 | $18,069,000 | +491.8% | 270,172 | +295.6% | 0.42% | +446.1% |
| Q3 2020 | $3,053,000 | +3.7% | 68,289 | -31.9% | 0.08% | +13.4% |
| Q2 2020 | $2,944,000 | +22.0% | 100,314 | 0.0% | 0.07% | +9.8% |
| Q1 2020 | $2,413,000 | -21.2% | 100,314 | -8.9% | 0.06% | 0.0% |
| Q4 2019 | $3,064,000 | +28.8% | 110,125 | 0.0% | 0.06% | +15.1% |
| Q3 2019 | $2,378,000 | -43.3% | 110,125 | -20.3% | 0.05% | -46.5% |
| Q2 2019 | $4,192,000 | +7.8% | 138,115 | -15.0% | 0.10% | +7.6% |
| Q1 2019 | $3,890,000 | +19.2% | 162,563 | -26.1% | 0.09% | -16.4% |
| Q4 2018 | $3,263,000 | -21.3% | 220,036 | -5.4% | 0.11% | -6.8% |
| Q3 2018 | $4,145,000 | +30.3% | 232,500 | 0.0% | 0.12% | +57.3% |
| Q2 2018 | $3,181,000 | +110.9% | 232,500 | +15.8% | 0.08% | +78.6% |
| Q1 2018 | $1,508,000 | +67.0% | 200,800 | +66.0% | 0.04% | +75.0% |
| Q4 2017 | $903,000 | -53.8% | 121,000 | 0.0% | 0.02% | -51.0% |
| Q3 2017 | $1,955,000 | +28.5% | 121,000 | +31.5% | 0.05% | +19.5% |
| Q2 2017 | $1,521,000 | -16.8% | 92,000 | 0.0% | 0.04% | -19.6% |
| Q1 2017 | $1,828,000 | +10.4% | 92,000 | +23.8% | 0.05% | +4.1% |
| Q4 2016 | $1,656,000 | +11.6% | 74,300 | 0.0% | 0.05% | +40.0% |
| Q3 2016 | $1,484,000 | – | 74,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,751,891 | $6,453,253 | 6.09% |
| Prosight Management, LP | 3,446,274 | $5,927,591 | 1.88% |
| AMH Equity Ltd | 550,000 | $946,000 | 1.04% |
| ORACLE INVESTMENT MANAGEMENT INC | 485,886 | $835,724 | 0.26% |
| Avidity Partners Management LP | 2,299,100 | $3,954,452 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,285,137 | $3,930,436 | 0.15% |
| Green Alpha Advisors, LLC | 101,090 | $173,875 | 0.13% |
| XTX Topco Ltd | 408,213 | $702,126 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 506,588 | $871 | 0.08% |
| RA Capital Management | 1,723,373 | $2,964,202 | 0.06% |